A citation-based method for searching scientific literature

A S Jakola, A J Skjulsvik, K S Myrmel, K Sjåvik, G Unsgård, S H Torp, K Aaberg, T Berg, H Y Dai, K Johnsen, R Kloster, O Solheim. Ann Oncol 2017
Times Cited: 129







List of co-cited articles
710 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
50

Comparison of a strategy favoring early surgical resection vs a strategy favoring watchful waiting in low-grade gliomas.
Asgeir S Jakola, Kristin S Myrmel, Roar Kloster, Sverre H Torp, Sigurd Lindal, Geirmund Unsgård, Ole Solheim. JAMA 2012
378
41

Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
Justin S Smith, Edward F Chang, Kathleen R Lamborn, Susan M Chang, Michael D Prados, Soonmee Cha, Tarik Tihan, Scott Vandenberg, Michael W McDermott, Mitchel S Berger. J Clin Oncol 2008
804
38

The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
Maarten M J Wijnenga, Pim J French, Hendrikus J Dubbink, Winand N M Dinjens, Peggy N Atmodimedjo, Johan M Kros, Marion Smits, Renske Gahrmann, Geert-Jan Rutten, Jeroen B Verheul,[...]. Neuro Oncol 2018
132
36

Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: a series of 1097 cases: clinical article.
Laurent Capelle, Denys Fontaine, Emmanuel Mandonnet, Luc Taillandier, Jean Louis Golmard, Luc Bauchet, Johan Pallud, Philippe Peruzzi, Marie Hélène Baron, Michèle Kujas,[...]. J Neurosurg 2013
258
32

Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
Jan C Buckner, Edward G Shaw, Stephanie L Pugh, Arnab Chakravarti, Mark R Gilbert, Geoffrey R Barger, Stephen Coons, Peter Ricci, Dennis Bullard, Paul D Brown,[...]. N Engl J Med 2016
498
30

Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis.
Philip C De Witt Hamer, Santiago Gil Robles, Aeilko H Zwinderman, Hugues Duffau, Mitchel S Berger. J Clin Oncol 2012
559
29

Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy.
Roland Roelz, David Strohmaier, Ramazan Jabbarli, Rainer Kraeutle, Karl Egger, Volker A Coenen, Astrid Weyerbrock, Peter C Reinacher. Sci Rep 2016
73
38

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
Daniel J Brat, Roel G W Verhaak, Kenneth D Aldape, W K Alfred Yung, Sofie R Salama, Lee A D Cooper, Esther Rheinbay, C Ryan Miller, Mark Vitucci, Olena Morozova,[...]. N Engl J Med 2015
22

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Brigitta G Baumert, Monika E Hegi, Martin J van den Bent, Andreas von Deimling, Thierry Gorlia, Khê Hoang-Xuan, Alba A Brandes, Guy Kantor, Martin J B Taphoorn, Mohamed Ben Hassel,[...]. Lancet Oncol 2016
245
21

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial.
M J van den Bent, D Afra, O de Witte, M Ben Hassel, S Schraub, K Hoang-Xuan, P-O Malmström, L Collette, M Piérart, R Mirimanoff,[...]. Lancet 2005
584
20


Prognostic factors for survival in adult patients with cerebral low-grade glioma.
Francesco Pignatti, Martin van den Bent, Desmond Curran, Channa Debruyne, Richard Sylvester, Patrick Therasse, Denes Afra, Philippe Cornu, Michel Bolla, Charles Vecht,[...]. J Clin Oncol 2002
585
18


European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas.
Michael Weller, Martin van den Bent, Jörg C Tonn, Roger Stupp, Matthias Preusser, Elizabeth Cohen-Jonathan-Moyal, Roger Henriksson, Emilie Le Rhun, Carmen Balana, Olivier Chinot,[...]. Lancet Oncol 2017
539
17

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
17


IDH1 and IDH2 mutations in gliomas.
Hai Yan, D Williams Parsons, Genglin Jin, Roger McLendon, B Ahmed Rasheed, Weishi Yuan, Ivan Kos, Ines Batinic-Haberle, Siân Jones, Gregory J Riggins,[...]. N Engl J Med 2009
15

Glioma extent of resection and its impact on patient outcome.
Nader Sanai, Mitchel S Berger. Neurosurgery 2008
802
14

Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Tomohiro Kawaguchi, Yukihiko Sonoda, Ichiyo Shibahara, Ryuta Saito, Masayuki Kanamori, Toshihiro Kumabe, Teiji Tominaga. J Neurooncol 2016
78
17

The role of surgery in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.
Manish K Aghi, Brian V Nahed, Andrew E Sloan, Timothy C Ryken, Steven N Kalkanis, Jeffrey J Olson. J Neurooncol 2015
101
14

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.
Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, Johan M Kros, Mathilde C M Kouwenhoven, Jean-Yves Delattre, Hans J J A Bernsen, Marc Frenay, Cees C Tijssen, Wolfgang Grisold,[...]. J Clin Oncol 2013
703
13



Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
13

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.
Edward G Shaw, Brian Berkey, Stephen W Coons, Dennis Bullard, David Brachman, Jan C Buckner, Keith J Stelzer, Geoffrey R Barger, Paul D Brown, Mark R Gilbert,[...]. J Neurosurg 2008
193
13

Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas.
Matthew J McGirt, Kaisorn L Chaichana, Frank J Attenello, Jon D Weingart, Khoi Than, Peter C Burger, Alessandro Olivi, Henry Brem, Alfredo Quinoñes-Hinojosa. Neurosurgery 2008
342
12


Continuous growth of mean tumor diameter in a subset of grade II gliomas.
Emmanuel Mandonnet, Jean-Yves Delattre, Marie-Laure Tanguy, Kristin R Swanson, Antoine F Carpentier, Hugues Duffau, Philippe Cornu, Rémy Van Effenterre, Ellsworth C Alvord, Laurent Capelle. Ann Neurol 2003
295
12

Chemotherapy for adult low-grade gliomas: clinical outcomes by molecular subtype in a phase II study of adjuvant temozolomide.
Michael Wahl, Joanna J Phillips, Annette M Molinaro, Yi Lin, Arie Perry, Daphne A Haas-Kogan, Joseph F Costello, Manisha Dayal, Nicholas Butowski, Jennifer L Clarke,[...]. Neuro Oncol 2017
67
16

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.
M J van den Bent, J S Wefel, D Schiff, M J B Taphoorn, K Jaeckle, L Junck, T Armstrong, A Choucair, A D Waldman, T Gorlia,[...]. Lancet Oncol 2011
322
11

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.
Roger Stupp, Warren P Mason, Martin J van den Bent, Michael Weller, Barbara Fisher, Martin J B Taphoorn, Karl Belanger, Alba A Brandes, Christine Marosi, Ulrich Bogdahn,[...]. N Engl J Med 2005
11


Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities.
J Pallud, P Varlet, B Devaux, S Geha, M Badoual, C Deroulers, P Page, E Dezamis, C Daumas-Duport, F-X Roux. Neurology 2010
124
10

Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.
Johan Pallud, Marie Blonski, Emmanuel Mandonnet, Etienne Audureau, Denys Fontaine, Nader Sanai, Luc Bauchet, Philippe Peruzzi, Marc Frénay, Philippe Colin,[...]. Neuro Oncol 2013
86
11

An extent of resection threshold for newly diagnosed glioblastomas.
Nader Sanai, Mei-Yin Polley, Michael W McDermott, Andrew T Parsa, Mitchel S Berger. J Neurosurg 2011
896
10

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.
Edward F Chang, Justin S Smith, Susan M Chang, Kathleen R Lamborn, Michael D Prados, Nicholas Butowski, Nicholas M Barbaro, Andrew T Parsa, Mitchel S Berger, Michael M McDermott. J Neurosurg 2008
153
9


Adult IDH wild-type lower-grade gliomas should be further stratified.
Abudumijit Aibaidula, Aden Ka-Yin Chan, Zhifeng Shi, Yanxi Li, Ruiqi Zhang, Rui Yang, Kay Ka-Wai Li, Nellie Yuk-Fei Chung, Yu Yao, Liangfu Zhou,[...]. Neuro Oncol 2017
118
9

Functional outcome after language mapping for glioma resection.
Nader Sanai, Zaman Mirzadeh, Mitchel S Berger. N Engl J Med 2008
640
9


MGMT gene silencing and benefit from temozolomide in glioblastoma.
Monika E Hegi, Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller, Johan M Kros, Johannes A Hainfellner, Warren Mason, Luigi Mariani,[...]. N Engl J Med 2005
9

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.
Walter Stummer, Uwe Pichlmeier, Thomas Meinel, Otmar Dieter Wiestler, Friedhelm Zanella, Hans-Jürgen Reulen. Lancet Oncol 2006
9


Survey on current cognitive practices within the European Low-Grade Glioma Network: towards a European assessment protocol.
Adrià Rofes, Emmanuel Mandonnet, John Godden, Marie Hélène Baron, Henry Colle, Amelie Darlix, Vânia de Aguiar, Hugues Duffau, Guillaume Herbet, Martin Klein,[...]. Acta Neurochir (Wien) 2017
44
18

Management of diffuse low-grade gliomas in adults - use of molecular diagnostics.
Jan Buckner, Caterina Giannini, Jeanette Eckel-Passow, Daniel Lachance, Ian Parney, Nadia Laack, Robert Jenkins. Nat Rev Neurol 2017
71
11

IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
Adriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, Lindsey E Heathcock, Hinke F van Thuijl, Mark R Gilbert, Terri S Armstrong, Erik P Sulman, Daniel P Cahill, Elizabeth Vera-Bolanos,[...]. Acta Neuropathol 2015
200
8

Biopsy versus resection for the management of low-grade gliomas.
Bowen Jiang, Kaisorn Chaichana, Anand Veeravagu, Steven D Chang, Keith L Black, Chirag G Patil. Cochrane Database Syst Rev 2017
25
32

Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
Edward F Chang, Matthew B Potts, G Evren Keles, Kathleen R Lamborn, Susan M Chang, Nicholas M Barbaro, Mitchel S Berger. J Neurosurg 2008
334
8

Mutational landscape and clonal architecture in grade II and III gliomas.
Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba, Yusuke Sato, Yusuke Shiozawa, Yuichi Shiraishi, Teppei Shimamura, Atsushi Niida, Kazuya Motomura, Fumiharu Ohka,[...]. Nat Genet 2015
489
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.